Citation

Bell TM, Bayt D, Zarzaur BL. Nicotine Tob. Res. 2015; 17(12): 1499-1504.

Affiliation

Indiana University School of Medicine, Department of Surgery, 702 Rotary Circle, Suite 022, Indianapolis, IN 46202.

Copyright

(Copyright © 2015, Society for Research on Nicotine and Tobacco, Publisher Oxford University Press)

DOI

10.1093/ntr/ntv027

PMID

25646350

Abstract

BACKGROUND: Studies evaluating the effect of smoking status on mortality outcomes in trauma patients have been limited, despite the fact that survival benefits of smoking have been reported in other critical care settings. The phenomenon "smoker's paradox" refers to the observation that following acute cardiovascular events, such as acute myocardial infarction and cardiac arrest, smokers often experience decreased mortality in the hospital setting. The objective of our study was to determine whether smoking imparts a survival benefit in patients with traumatic injuries.

METHODS: We performed a retrospective cohort study that analyzed cases included in the National Trauma Data Bank (NTDB) research dataset. Hierarchical logistic regression analyses were used to determine whether smoking alters the risk of mortality and complications in patients who smoke.

RESULTS: The percentage of patients experiencing mortality differed significantly between smokers (n=38,564) and non-smokers (n=319,249) (1.8% vs. 4.3%, p<0.001); however, the percentage experiencing a major complication did not (9.7% vs. 9.6%, p=0.763). Regression analyses indicated that smokers were significantly less likely to die during the hospital stay compared to non-smokers after adjusting for individual and hospital factors (OR 0.15, CI 0.10, 0.22). Additionally, smokers were also less likely to develop a major complication than non-smokers (OR 0.73, CI 0.59-0.91).

CONCLUSIONS: Patients who smoke appear to have a much lower risk of in-hospital mortality than non-smokers. Further investigation into biological mechanisms responsible for this effect should be carried out in order to potentially develop therapeutic applications.

Language: en